Sunshine Biopharma (SBFMW) Capital Expenditures Growth (3y) (2018 - 2025)
Sunshine Biopharma (SBFMW) Capital Expenditures Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 6.52% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 232.22% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 34.64% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 147.53% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 28.56% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -15.83% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -61.38% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 277.94% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26.10% |
| Dec 31, 2023 | -893.26% |
| Sep 30, 2023 | 129.21% |
| Dec 31, 2022 | 508.72% |
| Dec 31, 2020 | -52.80% |
| Sep 30, 2020 | 26.74% |
| Dec 31, 2019 | -7.76% |
| Jun 30, 2019 | -40.85% |
| Dec 31, 2018 | -55.74% |